Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

7 Minutes with 7 Executives

Bell Direct
April 12, 2024

Weekly Wrap 12 April

Grady Wulff
April 12, 2024

Morning Bell 12 April

Sam Kanaan
April 12, 2024

Morning Bell 11 April

Grady Wulff
April 11, 2024

Morning Bell 10 April

Grady Wulff
April 10, 2024

Morning Bell 9 April

Sam Kanaan
April 9, 2024

Morning Bell 8 April

Grady Wulff
April 8, 2024

Morning Bell 5 April

Sam Kanaan
April 5, 2024

Morning Bell 4 April

Sophia Mavridis
April 4, 2024

Morning Bell 3 April

Grady Wulff
April 3, 2024

Morning Bell 2 April

Sam Kanaan
April 2, 2024